Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.4.2' was added and a general funding/operating status notice previously displayed on the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:20:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice was added and the page revision updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:30:51.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Additions: glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:49.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a backend version update with no change to the study data presented.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations now include Ohio as a study site; the Ohio Locations entry was removed and the HHS Vulnerability Disclosure footer link was deleted.
    Difference
    0.2%
    Check dated 2025-12-23T10:41:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.